Normal
09th-10th March 2023

MarketsandMarkets OncoGene 2023

ILEC Conference Centre & Ibis London Earls Court, London

With the advent of new technological advancements in medical research and diagnostic strategies, early disease diagnosis and prevention has witnessed a medical revolution. We are proud to present to you our ‘OncoGene’ ConfEx in London scheduled on 9th – 10th March 2023. This ConfEx is an assemblage of 3 inextricably linked conferences like 7th Annual Next-Gen Immuno-Oncology Conference, Next-Gen Genomics and Proteomics Conference and Precision Medicine Conference which will accommodate diverse sessions on cutting edge discussions via Presentations, Exhibitions, Speaker QnAs, Panel discussions or Breakout sessions.

Next Gen Immuno Oncology

Next-Gen Immuno-Oncology

Immuno-Oncology

Cancer Biomarkers

Cancer Genetics

Cell and Gene Therapy

Immunology

Immunotherapy

Tumor Biology

Antibody Development

Oncolytic Viruses

Immune Checkpoint Inhibitors

Next-Gen-Genomics-Proteomics

Next-Gen Genomics  & Proteomics

Genomics|Proteomics

Computational Biology

Structural Biology

Functional Genomics

Mass Spectrometry

Liquid Chromatography

Multi-Omics Science

Protein Science

Translational Biology

Precision-Medicine

Precision Medicine

Personalized Medicine

Digital Biomarkers

Complex | Chronic | Rare Disease

Genome Sequencing

Artificial Intelligence and Machine Learning

Translational Medicine

Genomic Medicine

Molecular Medicine

Drug Discovery

The ConfEx aims to bring together the full spectrum of experts, leaders and shareholders from global pharmaceutical organizations, biotech and therapeutical companies, and internationally eminent research and academic institutions to share broad perspective on advancements and solutions to most critical challenges in the areas of Immuno-Oncology, Advancements in Genomics and Proteomics and Personalized Medicine Approaches.

The eagerly anticipated ConfEx is intended to have interactive sessions on the application of each area in complex disease prediction, quantitative analysis of genomic and proteomic tools and federal efforts in developing the hyperindividualized therapy. The discussion also encompasses the latest advantages of clinical data,digitalization in healthcare and dynamic therapeutic innovations.

Co-Located Conferences
WHAT TO EXPECT

Key Highlights

  1. Use of digital biomarkers for drug development, Multi-Omics prospects (Epigenomics, Proteomics, Transcriptomics, Pharmaco genomics)
  2. Inception of technologies for Precision Medicine – Impact of big data, Artificial intelligence, and Machine Learning, Insilico trials for Precision medicine
  3. Cost benefit issues, Regulatory, Ethical and Social challenges in Precision Medicine
  4. Updates in development of ADC’s and Bispecific Ab’s
  5. Immune Checkpoint Inhibitors and Combinations
  6. CAR-T Cell therapy, TCR Based-Cell Therapy
  7. Tumor microenvironment and Oncolytic Viruses
  8. Gene Expression and Molecular Mechanism in Immune Signaling, Flow Cytometry in Immune Phenotyping, Polygenic Risk Scores for Immuno Metabolic Markers
  9. Electrospray Mass Spectrometry based Biomarkers, Development of Multidimensional Liquid Chromatography, Spatial Profiling in Tumor Proteomics
  10. Advances in Genome Wide Variant Data and Application of Omics in Protein – Protein interaction

Why Attend?

  • Witness live action how precision medicine is revolutionizing the future of healthcare
  • Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing precision medicine
  • Discover the different avenues in patient centric care
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
  • Comprehend the current and future research avenues in drug discovery using Genomics and Proteomics
  • Discuss the emerging technologies and opportunities with cutting edge strategies
  • Opportunity for one-on-one networking with the delegates and extend professional competency

Who Should Attend?

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science

CONFERENCE AGENDA
Enquire Now

Sponsor/Exhibit Delegate
CONFERENCE SPEAKERS
Advisors
Alex F Frangi
Alex F Frangi
Diamond Jubilee Chair in Computational Medicine & RAEng Chair in Emerging Technologies, University of Leeds & KU Leuven - Turing Fellow
Manuel Corpas
Manuel Corpas
Scientific Director, Cambridge Precision Medicine
Arunima Ghosh
Arunima Ghosh
Managing director Indivumed Inc VP, Clinical network, USA, Indivumed
Lahiri Kanth Nanduri
Lahiri Kanth Nanduri
Lead Scientific Officer, FlowCell
Mark Stern
Mark Stern
Senior Director, Head Clinical Genetics and Genomics, Bristol Myers Squibb
Kenneth Linton
Kenneth Linton
Professor of Protein Biochemistry, Queen Mary University of London
Ricardo Carreira
Ricardo Carreira
Associate Director - Proteomics, Immunocore
Speakers
John Maher
John Maher
Scientific Founder and Chief Scientific Officer, Leucid Bio
Dr Steve Gardner
Dr Steve Gardner
CEO and Co-founder, PrecisionLife, UK
Jennifer Barnett
Jennifer Barnett
CEO, Monument Therapeutics
Christoph A. Merten
Christoph A. Merten
, École Polytechnique Fédérale de Lausanne (EPFL)
Andrew Pierce
Andrew Pierce
Vice President, Translational Biology, Crescendo Biologics
Hemant Dhamne
Hemant Dhamne
Head of Vector and CAR-T Cell Processing, Immuneel Therapeutics Pvt Ltd
Sabina Patel
Sabina Patel
Director, Diagnostic Expert, AstraZeneca
Milena Kalaitsidou
Milena Kalaitsidou
Principal Scientist, Instil Bio
Please contact [email protected] for speaking opportunity
SPONSORS
Gold
example-image

Sengenics

example-image

Proteome Sciences

Silver
example-image

EpigenDx

example-image

Bionano Genomics

example-image

BD Biosciences

example-image

Lunaphore Technologies

Speaking Partner
example-image

TransCure bioServices

example-image

Veracyte

Exhibition Partner
example-image

Biognosys

example-image

Cureline

example-image

Agilent

example-image

Canopy Biosciences

example-image

Quantabio

example-image

GeneFirst

example-image

PeproTech

Meeting Partner
example-image

Talem Therapeutics

PARTNERS
Supporting Association
Mab Design

Mab Design

LOCATION
ILEC Conference Centre & Ibis London Earls Court, London
About the Hotel

PAST EVENT GALLERY